Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Laplaud, D. (David A)"'
Autor:
Deschamps, R. (Romain), Pique, J. (Julie), Ayrignac, X. (Xavier), Collongues, N. (Nicolas), Audoin, B. (Bertrand), Zéphir, H. (Hélène), Ciron, J. (Jonathan), Cohen, M. (Mikael), Aboab, J. (Jennifer), Mathey, G. (Guillaume), Derache, N. (Nathalie), Laplaud, D. (David), Thouvenot, E. (Eric), Bourre, B. (Bertrand), Ruet, A. (Aurélie), Durand-Dubief, F. (Françoise), Touitou, V. (Valérie), Vignal-Clermont, C. (Catherine), Papeix, C. (Caroline), Gout, O. (Olivier), Marignier, R. (Romain), Maillart, E. (Elisabeth)
BACKGROUND AND OBJECTIVE: The prognosis in myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is a matter of debate. Our aim was to assess the long-term outcomes of patients with MOGAD. METHODS: We retrospectively analysed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4060::3aaf40c2e86cf17dfc4af0366d6ba14e
Autor:
Louapre, C. (Céline), Collongues, N. (Nicolas), Stankoff, B. (Bruno), Giannesini, C. (Claire), Papeix, C. (Caroline), Bensa, C. (Caroline), Deschamps, R. (Romain), Créange, A. (Alain), Wahab, A. (Abir), Pelletier, J. (Jean), Heinzlef, O. (Olivier), Labauge, P. (Pierre), Guilloton, L. (Laurent), Ahle, G. (Guido), Goudot, M. (Mathilde), Bigaut, K. (Kevin), Laplaud, D. (David-Axel), Vukusic, S. (Sandra), Lubetzki, C. (Catherine), De Sèze, J. (Jérôme)
Importance: Risk factors associated with the severity of coronavirus disease 2019 (COVID-19) in patients with multiple sclerosis (MS) are unknown. Disease-modifying therapies (DMTs) may modify the risk of developing a severe COVID-19 infection, besid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4060::90c840efb19bc53ff3430b925aba1c27
Autor:
Barbin, L. (Laetitia), Rousseau, C. (Chloe), Jousset, N. (Natacha), Casey, R. (Romain), Debouverie, M. (Marc), Vukusic, S. (Sandra), De Seze, J. (Jerome), Brassat, D. (David), Wiertlewski, S. (Sandrine), Brochet, B. (Bruno), Pelletier, J. (Jean), Vermersch, P. (Patrick), Edan, G. (Gilles), Lebrun-Frenay, C. (Christine), Clavelou, P. (Pierre), Thouvenot, E. (Eric), Camdessanché, J. (Jean-Philippe), Tourbah, A. (Ayman), Stankoff, B. (Bruno), Al Khedr, A. (Abdullatif), Cabre, P. (Philippe), Papeix, C. (Caroline), Berger, E. (Eric), Heinzlef, O. (Olivier), Debroucker, T. (Thomas), Moreau, T. (Thibault), Gout, O. (Olivier), Bourre, B. (Bertrand), Créange, A. (Alain), Labauge, P. (Pierre), Magy, L. (Laurent), Defer, G. (Gilles), Foucher, Y. (Yohann), Laplaud, D. (David A), CFSEP and OFSEP groups
Publikováno v:
Neurology
Neurology, 2016, 86 (8), pp.771-778. ⟨10.1212/WNL.0000000000002395⟩
Neurology, American Academy of Neurology, 2016, 86 (8), pp.771-778. ⟨10.1212/WNL.0000000000002395⟩
Neurology, 2016, 86 (8), pp.771-778. ⟨10.1212/WNL.0000000000002395⟩
Neurology, American Academy of Neurology, 2016, 86 (8), pp.771-778. ⟨10.1212/WNL.0000000000002395⟩
OBJECTIVE: To compare natalizumab and fingolimod on both clinical and MRI outcomes in patients with relapsing-remitting multiple sclerosis (RRMS) from 27 multiple sclerosis centers participating in the French follow-up cohort Observatoire of Multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c73a86ed2bee10e58974c4f61412e182
https://doi.org/10.1212/WNL.0000000000002395
https://doi.org/10.1212/WNL.0000000000002395